newsfilter
← Latest News
GlobeNewswire·

Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares

WESTPORT, Conn., March 26, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ:PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today